在过去的 10 年中，《澳大利亚和新西兰眼科学杂志》和《临床与实验眼科杂志》的出版和引文分析：一本眼科学杂志的演变。

Publication and citation analysis of the Australian and New Zealand Journal of Ophthalmology and Clinical and Experimental Ophthalmology over a 10-year period: the evolution of an ophthalmology journal.

机构信息

Department of Ophthalmology, New Zealand National Eye Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.

出版信息

Clin Exp Ophthalmol. 2009 Dec;37(9):868-73. doi: 10.1111/j.1442-9071.2009.02191.x.

DOI:10.1111/j.1442-9071.2009.02191.x

PMID:20092596

Abstract

PURPOSE

To analyse the pattern of change in publication content and citations generated by a mid-ranking ophthalmology journal as it evolved from the Australian and New Zealand Journal of Ophthalmology (ANZJO) to its successor, Clinical 0mp; Experimental Ophthalmology (CEO).

METHODS

The Science Citation Index was used to analyse the publications of ANZJO and CEO over two 10-year periods (1990-1999 and 2000-2009, respectively). Publication and citation patterns were analysed in terms of source authors, institutions and countries. As a secondary measure, journal impact factors (JIFs) were retrieved from the Journal Citation Reports at the end of each period.

RESULTS

Over the specified periods, 859 articles published in ANZJO were cited 1210 times, and 1529 articles published in CEO were cited 5374 times. Australia was the largest contributing country to both journals; however, the proportional contributions from other countries including New Zealand, UK, USA, India and China increased significantly in CEO. Articles were cited by authors from 793 institutions in 60 countries for ANZJO and 2997 institutions in 95 countries for CEO. The contribution by key authors (identified as the top 10 most-published authors) towards total journal publications was 24% in ANZJO, but only 16% in CEO; however, these publications were responsible for 26.6% and 28.8% of the total citations, respectively. With respect to the most recent JIFs, ANZJO was 0.433 in 1999 (ranked 33 of 43 journals) and CEO was 1.35 in 2008 (ranked 27 of 48 journals).

CONCLUSION

CEO has substantially increased the number of publications, citation counts and international sources compared with its well-established predecessor, ANZJO, over the assessed periods. CEO also appears to have a higher international profile with increasing citations counts from more countries. This evolution from a regional, to a more international, journal has been substantial and is reflected by a significant increment in JIF, and a modest increase in overall JIF-ranking, for CEO.

摘要

目的

分析一本中等水平的眼科学期刊在从《澳大利亚和新西兰眼科学杂志》（ANZJO）演变为《临床与实验眼科学》（CEO）的过程中，其出版内容和引用文献的变化模式。

方法

利用科学引文索引（Science Citation Index），对 ANZJO 和 CEO 在两个 10 年期间（1990-1999 年和 2000-2009 年）的出版物进行分析。根据来源作者、机构和国家，分析出版物和引用模式。作为次要衡量标准，在每个时期结束时从期刊引文报告（Journal Citation Reports）中检索期刊影响因子（JIF）。

结果

在所规定的时间段内，ANZJO 发表的 859 篇文章被引用了 1210 次，而 CEO 发表的 1529 篇文章被引用了 5374 次。澳大利亚是两个期刊最大的贡献国，但包括新西兰、英国、美国、印度和中国在内的其他国家的比例贡献在 CEO 中显著增加。ANZJO 有 793 个机构的作者引用了 60 个国家的文章，而 CEO 有 2997 个机构的作者引用了 95 个国家的文章。对期刊总出版物贡献最大的 10 位作者（确定为发表文章最多的前 10 位作者）的贡献在 ANZJO 中占 24%，而在 CEO 中仅占 16%；然而，这些出版物分别占总引文的 26.6%和 28.8%。关于最近的 JIF，ANZJO 在 1999 年为 0.433（43 种期刊中排名第 33），而 CEO 在 2008 年为 1.35（48 种期刊中排名第 27）。